-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
OncoSec Medical Incorporated (NASDAQ:ONCS) Short Interest Down 60.2% in December
OncoSec Medical Incorporated (NASDAQ:ONCS) Short Interest Down 60.2% in December
OncoSec Medical Incorporated (NASDAQ:ONCS – Get Rating) saw a large decline in short interest in December. As of December 30th, there was short interest totalling 45,700 shares, a decline of 60.2% from the December 15th total of 114,700 shares. Currently, 3.2% of the shares of the company are short sold. Based on an average daily volume of 897,800 shares, the days-to-cover ratio is presently 0.1 days.
OncoSec Medical Trading Down 13.4 %
Shares of NASDAQ:ONCS traded down $0.34 during trading on Wednesday, hitting $2.19. 267,558 shares of the stock were exchanged, compared to its average volume of 348,514. The company has a fifty day moving average price of $4.55 and a two-hundred day moving average price of $10.26. The company has a market cap of $6.50 million, a PE ratio of -0.13 and a beta of 1.59. OncoSec Medical has a 12-month low of $1.50 and a 12-month high of $31.90.
Get OncoSec Medical alerts:Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on ONCS shares. StockNews.com started coverage on OncoSec Medical in a research note on Sunday, January 8th. They set a "sell" rating on the stock. BTIG Research lowered OncoSec Medical from a "buy" rating to a "neutral" rating in a research note on Monday, November 14th.
Institutional Inflows and Outflows
An institutional investor recently raised its position in OncoSec Medical stock. Bank of New York Mellon Corp increased its stake in shares of OncoSec Medical Incorporated (NASDAQ:ONCS – Get Rating) by 653.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 386,074 shares of the biotechnology company's stock after purchasing an additional 334,849 shares during the period. Bank of New York Mellon Corp owned 0.98% of OncoSec Medical worth $444,000 as of its most recent SEC filing.OncoSec Medical Company Profile
(Get Rating)
OncoSec Medical, Inc is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor.
See Also
- Get a free copy of the StockNews.com research report on OncoSec Medical (ONCS)
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
- Does it Matter Folks Aren't "Starry-Eyed" Over Pepsi's New Soda?
- Can Alaska Air Continue Soaring Above The Airline Industry?
Receive News & Ratings for OncoSec Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OncoSec Medical and related companies with MarketBeat.com's FREE daily email newsletter.
OncoSec Medical Incorporated (NASDAQ:ONCS – Get Rating) saw a large decline in short interest in December. As of December 30th, there was short interest totalling 45,700 shares, a decline of 60.2% from the December 15th total of 114,700 shares. Currently, 3.2% of the shares of the company are short sold. Based on an average daily volume of 897,800 shares, the days-to-cover ratio is presently 0.1 days.
歐科證券交易委員會醫療股份有限公司（NASDAQ：ONCS-獲得評級）在十二月份出現了短期利益大幅下降。截至 12 月 30 日，總共有 45,700 股短期利息，較十二月十五日總額 114,700 股股份下降 60.2%。目前，該公司 3.2％ 的股份賣空。根據每日平均成交量為 897,800 股，日數佔覆蓋比率目前為 0.1 天。
OncoSec Medical Trading Down 13.4 %
腫瘤證券交易指數下跌 13.4%
Shares of NASDAQ:ONCS traded down $0.34 during trading on Wednesday, hitting $2.19. 267,558 shares of the stock were exchanged, compared to its average volume of 348,514. The company has a fifty day moving average price of $4.55 and a two-hundred day moving average price of $10.26. The company has a market cap of $6.50 million, a PE ratio of -0.13 and a beta of 1.59. OncoSec Medical has a 12-month low of $1.50 and a 12-month high of $31.90.
納斯達克股票:ONCS 周三交易期間下跌 0.34 美元，觸及 2.19 美元。267,558 股股票被交換，相比其平均成交量 348,514。該公司的五十天移動平均價格為 4.55 美元，兩百天移動平均價為 10.26 美元。該公司的市值為 650 萬美元，私募股權比率為 -0.13，測試版為 1.59。癌症醫療有 12 個月的低點 1.50 美元和 12 個月的最高點 31.90 美元。
Analyst Upgrades and Downgrades
分析師升級和降級
Several equities research analysts have recently commented on ONCS shares. StockNews.com started coverage on OncoSec Medical in a research note on Sunday, January 8th. They set a "sell" rating on the stock. BTIG Research lowered OncoSec Medical from a "buy" rating to a "neutral" rating in a research note on Monday, November 14th.
幾位股票研究分析師最近對 ONCS 的股票發表了評論。Stocknews.com 於 1 月 8 日（星期日）在一份研究報告中開始對安科醫療保險公司的報導。他們在股票上設置了「賣出」評級。BTIG 研究在 11 月 14 日星期一的研究報告中將 OncoSEC 醫療從「購買」評級降低到「中性」評級。
Institutional Inflows and Outflows
機構流入和流出
OncoSec Medical Company Profile
醫療公司簡介
(Get Rating)
(取得評分)
OncoSec Medical, Inc is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor.
OncoSec Medical, Inc 是一家生物技術公司，專注於設計，開發和商業化療法以及專有的醫療方法，以刺激和指導抗腫瘤免疫反應以用於治療癌症。其主要候選產品 Immunopulse IL-12 使用電滲裝置，目的是逆轉治療腫瘤中的免疫抑制微環境。
See Also
另請參閱
- Get a free copy of the StockNews.com research report on OncoSec Medical (ONCS)
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
- Does it Matter Folks Aren't "Starry-Eyed" Over Pepsi's New Soda?
- Can Alaska Air Continue Soaring Above The Airline Industry?
- 免費索取有關癌症醫療研究報告
- NU 控股股票與沃倫·巴菲特有什麼關係？
- J.B. 亨特得到一個單位, 物流公司成為焦點
- 英特爾股票是否瀕臨爆發？
- 這是否重要的人不是「星眼」在百事可樂的新蘇打水?
- 阿拉斯加航空能否繼續飆升至航空業之上？
Receive News & Ratings for OncoSec Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OncoSec Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接收有關 OncoSEC 醫療日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收有關 OncoSec 醫療和相關公司的最新新聞和分析師評級的簡要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧